E.coli Testing Market is expected to reach US$ 2,527.73 Mn by 2027

Monoclonal Antibodies Segment to Drive Growth of E. coli Testing Market during 2020–2027

According to our new market research study titled "E. coli Testing Market –Global Analysis and Forecast – by Technology and End User," the global E. coli testing market is expected to reach US$ 2,527.73 million by 2027 from US$ 1,506.95 million in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. The report highlights the trends prevalent in the global E. coli testing market, and the drivers and deterrents pertaining to its growth.

The E. coli testing market, by technology, is segmented monoclonal antibodies, differential light scattering, molecular diagnostics, immunoassays, chromatography, flow cytometry, gel microdroplets, and diagnostic imaging. The monoclonal antibodies segment held the largest share of the market in 2019. Monoclonal antibodies are widely used to detect the strains of E. coli in water and clinical samples, and they can identify a single epitope within an antigen, which is an advantage over the polyclonal antibodies. Thus, it is expected to retain its dominance during the forecast period. However, the immunoassays segment is estimated to register the highest CAGR in the market during the forecast period.

The growth of the market is attributed to the factors such as increasing E. coli testing needs, growing product innovations, and rising research activities. On the other hand, testing challenges is the major factor is likely to restraint the market growth during the forecast period.

A few of the prominent players operating in the E. coli testing market are Bio-Rad Laboratories, Inc; Pro-Lab Diagnostics, Inc.; Abbott (Alere Inc.); IDEXX Laboratories, Inc.; Meridian Bioscience, Inc.; BD; Thermo Fisher Scientific, Inc.; CPI International; Biomerieux Inc.; and Hologic, Inc.  The market players are focused on acquisitions of other industry players to sustain their position in the market. For instance, in March, 2019, Meridian acquired GenePOC's molecular diagnostics business portfolio, with a main objective to leverage the rapid, high-quality diagnostics testing solutions of GenePOC as well as to guide and support the diagnosis for facilitating targeted therapeutic decisions for infectious diseases.

Global E. coli Testing Market, By Region, 2019 (%)

---

E. coli Testing Market Key Findings and Share by 2031

Download Free Sample

---

E. coli Testing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, Diagnostic Imaging); End User (Commercial or Private Labs, Physician Offices, Hospitals, Public Health Labs, Academic Research Institutes), and Geography

The report segments the global E. coli testing market as follows:

Global E. coli Testing Market – By Technology

• Monoclonal Antibodies
• Differential Light Scattering
• Molecular Diagnostics
• Immunoassays
• Chromatography
• Flow Cytometry
• Gel Microdroplets
• Diagnostic Imaging

Global E. coli Testing Market – By End User

• Commercial or Private Labs
• Physician Offices
• Hospitals
• Public Health Labs
• Academic Research Institutes

Global E. coli Testing Market – By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific (APAC)
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia
• South and Central America (SCAM)
  • Brazil
  • Argentina